Garcia-Vallejo JJ - Search Results

1

Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.

Duinkerken S, Horrevorts SK, Kalay H, Ambrosini M, Rutte L, de Gruijl TD, Garcia-Vallejo JJ, van Kooyk Y. Duinkerken S, et al. Theranostics. 2019 Aug 12;9(20):5797-5809. doi: 10.7150/thno.35059. eCollection 2019. Theranostics. 2019. PMID: 31534520 Free PMC article.

2

Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.

van Kooyk Y, Unger WW, Fehres CM, Kalay H, García-Vallejo JJ. van Kooyk Y, et al. Mol Immunol. 2013 Sep;55(2):143-5. doi: 10.1016/j.molimm.2012.10.031. Epub 2012 Nov 14. Mol Immunol. 2013. PMID: 23158834 Review.

3

Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.

Fehres CM, Kalay H, Bruijns SC, Musaafir SA, Ambrosini M, van Bloois L, van Vliet SJ, Storm G, Garcia-Vallejo JJ, van Kooyk Y. Fehres CM, et al. J Control Release. 2015 Apr 10;203:67-76. doi: 10.1016/j.jconrel.2015.01.040. Epub 2015 Feb 2. J Control Release. 2015. PMID: 25656175

4

MPLA incorporation into DC-targeting glycoliposomes favours anti-tumour T cell responses.

Boks MA, Ambrosini M, Bruijns SC, Kalay H, van Bloois L, Storm G, Garcia-Vallejo JJ, van Kooyk Y. Boks MA, et al. J Control Release. 2015 Oct 28;216:37-46. doi: 10.1016/j.jconrel.2015.06.033. Epub 2015 Jul 4. J Control Release. 2015. PMID: 26151293

5

Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells.

Fehres CM, Duinkerken S, Bruijns SC, Kalay H, van Vliet SJ, Ambrosini M, de Gruijl TD, Unger WW, Garcia-Vallejo JJ, van Kooyk Y. Fehres CM, et al. Cell Mol Immunol. 2017 Apr;14(4):360-370. doi: 10.1038/cmi.2015.87. Epub 2015 Oct 12. Cell Mol Immunol. 2017. PMID: 26456691 Free PMC article.

6

Apoptotic vesicles as tumor vaccine.

Horrevorts SK, Garcia-Vallejo JJ, van Vliet SJ, van de Loosdrecht AA, van Kooyk Y, de Gruijl TD. Horrevorts SK, et al. Immunotherapy. 2016;8(1):5-8. doi: 10.2217/imt.15.96. Epub 2015 Dec 7. Immunotherapy. 2016. PMID: 26641072 No abstract available.

7

Toll-Like Receptor 4 Triggering Promotes Cytosolic Routing of DC-SIGN-Targeted Antigens for Presentation on MHC Class I.

Horrevorts SK, Duinkerken S, Bloem K, Secades P, Kalay H, Musters RJ, van Vliet SJ, García-Vallejo JJ, van Kooyk Y. Horrevorts SK, et al. Front Immunol. 2018 Jun 14;9:1231. doi: 10.3389/fimmu.2018.01231. eCollection 2018. Front Immunol. 2018. PMID: 29963041 Free PMC article.

8

Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity.

Schetters STT, Li RJE, Kruijssen LJW, Engels S, Ambrosini M, Garcia-Vallejo JJ, Kalay H, Unger WWJ, van Kooyk Y. Schetters STT, et al. Biomaterials. 2020 Dec;262:120342. doi: 10.1016/j.biomaterials.2020.120342. Epub 2020 Aug 28. Biomaterials. 2020. PMID: 32905903 Free article.

9

Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8⁺ T cells.

Schetters STT, Jong WSP, Horrevorts SK, Kruijssen LJW, Engels S, Stolk D, Daleke-Schermerhorn MH, Garcia-Vallejo J, Houben D, Unger WWJ, den Haan JMM, Luirink J, van Kooyk Y. Schetters STT, et al. Acta Biomater. 2019 Jun;91:248-257. doi: 10.1016/j.actbio.2019.04.033. Epub 2019 Apr 17. Acta Biomater. 2019. PMID: 31003032 Free article.

10

Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses.

van Vliet SJ, García-Vallejo JJ, van Kooyk Y. van Vliet SJ, et al. Immunol Cell Biol. 2008 Oct;86(7):580-7. doi: 10.1038/icb.2008.55. Epub 2008 Aug 5. Immunol Cell Biol. 2008. PMID: 18679407 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page